Norges Bank’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $31.3M | Buy |
|
|||||
2025
Q1 | – | Sell |
|
|||||
2024
Q4 | $38.5M | Buy |
|
|||||
2024
Q3 | – | Sell |
|
|||||
2024
Q2 | $17.5M | Buy |
|
|||||
2024
Q1 | $8.54M | Sell |
|
|||||
2023
Q4 | $14.4M | Buy |
|
|||||
2023
Q3 | $10.6M | Sell |
|
|||||
2023
Q2 | $83.9M | Buy |
|
|||||
2023
Q1 | $29.2M | Buy |
|
|||||
2022
Q4 | $10.2M | Buy |
|
|||||
2022
Q3 | $7.22M | Buy |
|
|||||
2022
Q2 | $2.33M | Buy |
|
|||||
2022
Q1 | – | Sell |
|
|||||
2021
Q4 | $1.2M | Sell |
|
|||||
2021
Q3 | $2.94M | Sell |
|
|||||
2021
Q2 | $26.1M | Hold |
|
|||||
2021
Q1 | $30.4M | Sell |
|
|||||
2020
Q4 | $29.7M | Buy |
|
|||||
2020
Q3 | $25M | Buy |
|
|||||
2020
Q2 | $22.5M | Sell |
|
|||||
2020
Q1 | $76.1M | Hold |
|
|||||
2019
Q4 | $83.1M | Buy |
|
|||||
2019
Q3 | $56.9M | Hold |
|
|||||
2019
Q2 | $76.3M | Sell |
|
|||||
2019
Q1 | $144M | Sell |
|
|||||
2018
Q4 | $146M | Sell |
|
|||||
2018
Q3 | $214M | Sell |
|
|||||
2018
Q2 | $248M | Buy |
|
|||||
2018
Q1 | $157M | Hold |
|
|||||
2017
Q4 | $174M | Sell |
|
|||||
2017
Q3 | $172M | Sell |
|
|||||
2017
Q2 | $374M | Sell |
|
|||||
2017
Q1 | $367M | Sell |
|
|||||
2016
Q4 | $496M | Sell |
|
|||||
2016
Q3 | $618M | Sell |
|
|||||
2016
Q2 | $723M | Buy |
|
|||||
2016
Q1 | $636M | Buy |
|
|||||
2015
Q4 | $682M | Buy |
|
|||||
2015
Q3 | $530M | Hold |
|
|||||
2015
Q2 | $555M | Sell |
|
|||||
2015
Q1 | $655M | Buy |
|
|||||
2014
Q4 | $554M | Buy |
|
|||||
2014
Q3 | $507M | Sell |
|
|||||
2014
Q2 | $989M | Buy |
|
|||||
2014
Q1 | $408M | Hold |
|
|||||
2013
Q4 | $309M | Hold |
|
|||||
2013
Q3 | $292M | Sell |
|
|||||
2013
Q2 | $328M | Buy |
|